Glymidine sodium
From Self-sufficiency
| File:Glymidine.png | |
| Systematic (IUPAC) name | |
|---|---|
|
N-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzenesulfonamide | |
| Clinical data | |
| Routes of administration | Oral |
| Pharmacokinetic data | |
| Bioavailability | High |
| Protein binding | 90% |
| Biological half-life | 3.8 hours |
| Identifiers | |
| CAS Number | 339-44-6 |
| ATC code | A10BC01 (WHO) |
| PubChem | CID 9565 |
| DrugBank | DB01382 |
| Chemical data | |
| Formula | C13H15N3O4S |
| Molar mass | 309.34 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
| (verify) | |
Glymidine sodium (INN, also known as glycodiazine; trade name Gondafon) is a sulfonamide antidiabetic drug, structurally related to the sulfonylureas. It was first reported in 1964, and introduced to clinical use in Europe in the mid to late 1960s.[1]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Sulfonamides
- Pyrimidines
- Ethers
- Phenol ethers
- Gastrointestinal system drug stubs
- 2Fix
